A prospective study to evaluate the effects of sodium-glucose cotransporter 2 inhibitors in type 2 diabetic patients with chronic kidney disease

A prospective study to evaluate the effects of sodium-glucose cotransporter 2 inhibitors in type 2 diabetic patients with chronic kidney disease

Introduction: Recent studies suggest that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are effective at slowing the progression of kidney disease and lowering the risk of kidney failure in people with kidney disease and type 2 diabetes. There is no such study from India. The present study was...

Full description

Bibliographic Details
Main Authors: Neil Saldanha, Mita Shah, Monika S Dalal, Zaheer Amin Virani, Ishan Parekh, Hepal Vora, Prashant Rajput, Shruti Tapiawala, Bharat V Shah
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Diabetology
Subjects:
chronic kidney disease
diabetes mellitus
sglt2i
Online Access:http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2022;volume=13;issue=3;spage=301;epage=304;aulast=Saldanha

Similar Items

Similar Items